Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2020
Dec. 31, 2019
Current Assets    
Cash and cash equivalents $ 19,444,737 $ 16,966,168
Accounts Receivable 7,118 0
Prepaid expenses 303,178 267,518
Other current assets 576,660 322,593
Total Current Assets 20,331,693 17,556,279
Property and equipment, net 5,171,134 2,981,225
Operating lease right-of-use assets 326,085 381,483
Intangible assets, net 321,641 372,305
Total Assets 26,150,553 21,291,292
Current Liabilities    
Accounts payable 1,539,547 627,253
Accrued liabilities 3,491,740 2,168,588
Management and directors' fees payable 55,174 21,979
Current portion of long-term debt 841,319 647,569
Current portion of financing lease liabilities 59,930 97,946
Current portion of operating lease liabilities 179,624 257,244
Current portion of grant repayable 69,218 39,295
Total Current Liabilities 6,236,552 3,859,874
Long-term debt, net of current portion 2,606,885 2,195,278
Finance lease liabilities, net of current portion 601,967 607,708
Operating lease liabilities, net of current portion 151,828 131,875
Grant repayable, net of current portion 259,603 297,991
Total Liabilities 9,856,835 7,092,726
STOCKHOLDERS' EQUITY    
Authorized: 100,000,000 shares of common stock, at $0.001 par value, Issued and outstanding: 48,607,017 shares and 41,125,303 shares, respectively 48,607 41,125
Additional paid-in capital 126,526,239 103,853,627
Accumulated other comprehensive income (loss) (59,978) 125,670
Accumulated deficit (110,173,971) (89,821,856)
Total VolitionRx Limited Stockholders' Equity 16,340,897 14,198,566
Non-controlling interest (47,179) 0
Total Stockholders' Equity 16,293,718 14,198,566
Total Liabilities and Stockholders' Equity $ 26,150,553 $ 21,291,292